There's a three month trial period http://www.sabrinajanesch.de/autorin/ assurans  Aegerion, which received a positive opinion for the drug from the European Committee for Medicinal Products for Human Use in May, said it now expects a formal marketing approval in August. A CHMP nod increases the likelihood of an approval in European Union.